Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Cohen

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 30, 2017
Needle tract seeding following core biopsies in retroperitoneal sarcomaW J Van Houdt, A M Schrijver, R B Cohen-Hallaleh, et al.
Journal of Medicinal Chemistry|February 17, 1998
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potenciesK S Atwal, G J Grover, N J Lodge, et al.
The Journal of Infectious Diseases|October 1, 1993
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infectionB Y Nguyen, L E Shay, K M Wyvill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumorsL Gore, S N Holden, R B Cohen, et al.
Clinical Sarcoma Research|August 11, 2017
Radiation induced angiosarcoma of the breast: outcomes from a retrospective case seriesR B Cohen-Hallaleh, H G Smith, R C Smith, et al.
British Journal of Cancer|September 22, 2012
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursL P Martin, M F Kozloff, R S Herbst, et al.
British Journal of Cancer|May 18, 2006
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumoursM E Cianfrocca, K A Kimmel, J Gallo, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 14, 2009
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumorsR L Oostendorp, J Loftiss, S Goel, et al.
British Journal of Cancer|September 20, 2012
Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursM F Kozloff, L P Martin, M Krzakowski, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 30, 2017
Needle tract seeding following core biopsies in retroperitoneal sarcomaW J Van Houdt, A M Schrijver, R B Cohen-Hallaleh, et al.
Journal of Medicinal Chemistry|February 17, 1998
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potenciesK S Atwal, G J Grover, N J Lodge, et al.
The Journal of Infectious Diseases|October 1, 1993
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infectionB Y Nguyen, L E Shay, K M Wyvill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumorsL Gore, S N Holden, R B Cohen, et al.
Clinical Sarcoma Research|August 11, 2017
Radiation induced angiosarcoma of the breast: outcomes from a retrospective case seriesR B Cohen-Hallaleh, H G Smith, R C Smith, et al.
British Journal of Cancer|September 22, 2012
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursL P Martin, M F Kozloff, R S Herbst, et al.
British Journal of Cancer|May 18, 2006
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumoursM E Cianfrocca, K A Kimmel, J Gallo, et al.
AIDS (London, England)|November 5, 1999
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patientsL A Pinto, J A Berzofsky, K R Fowke, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 14, 2009
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumorsR L Oostendorp, J Loftiss, S Goel, et al.
British Journal of Cancer|September 20, 2012
Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursM F Kozloff, L P Martin, M Krzakowski, et al.
Pageof 10